Followers | 1173 |
Posts | 21667 |
Boards Moderated | 4 |
Alias Born | 08/11/2012 |
Tuesday, November 04, 2014 8:51:11 AM
News Release Verde Science R
Nov 04, 2014 (ACCESSWIRE via COMTEX) -- Verde Science R&D Team Ready To Move Forward With Design Of Research Plan
Image: https://www.baystreet.ca/uploads/eyukuVRCI.png
Richmond, BC / ACCESSWIRE / November 4, 2014 / (OTCPK: VRCI) Verde Science, Inc., a Medical Research and Development Company, is pleased to announce that it has assembled its complete Research and Development team under the direction of its newly appointed Chief Technology Officer, Manit Patel, and it has initiated the coordinated design of its overarching R&D plan. The recently completed team includes:
- Manit Patel, CTO - B.Sc. in Pharmaceutical Science from the Institute of Chemical Technology of Mumbai, India. MBA from Queensland University of Technology in Brisbane, Australia. Expertise in pharmaceutical research, product design, production, and business strategy and development, with a broad network of international business contacts. He has successfully launched 9 products for Sterkem during his tenure.
- Drs. Ratnesh Jain and Prajatka Dandekar Jain, Senior Researchers - Dr. Prajakta Jain has a Ph.D. in Bioprocess Technology with expertise in extraction and isolation of active ingredients from plants. Dr. Ratnesh Jain has a Ph.D. in nanocarriers and drug delivery systems. Both researchers are faculty at the Institute of Chemical Technology and will be pivotal to cost effective extraction, isolation and formulation design from the marijuana plant.
- The Institute of Chemical Technology -The ICT and Verde Science are moving toward an alliance that will offer expanded research capabilities for Verde's ongoing scientific inquiries that will utilize faculty and graduate students to supplement Verde's internal scientists.
- Sterkem Group - Verde Science and Sterkem Group (www.sterkempharma.com) a Mumbai, India based pharmaceutical research, production and marketing firm, are finalizing the plan for a pharmaceutical development venture that will refine the resultant cannabis-based extracts for specific medical conditions identified by Verde's R&D program into deliverable and marketable pharmaceutical formulations.
"We are immediately beginning the coordinated design of our overall R&D program with our front end and back end team members in India, so that all members of the team will be constantly in the feedback loop throughout the R&D process for each compound we are studying", according to Manit Patel. "This approach along with our synergistic and highly skilled team will streamline our processes and yield optimal results, without having to wait for a R&D license in Canada", concluded Mr. Patel.
The Verde Science approach is a pharmacological/medical study of cannabis extracts that actually have an effect on specific medical conditions, while minimizing any deleterious effects of smoking medical marijuana or inhaling vapors that have diminished its use in mainstream medicine. The company's scientists have already identified certain cannabis extracts they believe show distinct promise for further study. Research will begin in India where marijuana research is far less regulated, costs are lower and traditional Indian medicine has been advocating the use of marijuana to treat certain medical conditions for centuries. This expedited and low cost scientific approach sets Verde Science apart from most in the medical marijuana space, as the company has no intention to become a licensed marijuana grower/operator in Canada or the United States, nor does it intend to apply for a MMPR license with Health Canada. Verde Science is discussing possible collaborations with private companies that have applied for a Medical Marijuana R&D only license from Health Canada and are awaiting final approvals. The process and requirements to receive a R&D license can be found on the Health Canada Website ( www.hc-sc.gc.ca) (http://www.hc-sc.gc.ca/hc-ps/substancontrol/exemptions/applic-scien-eng.php) (Some of the statements in this paragraph are clarifying statements made at the request of the British Columbia Securities Commission.)
About Verde Science, Inc. (VRCI)
Verde Science, Inc. (www.VerdeScienceInc.com) is a public company trading under the symbol OTCPK: VRCI. The Company is focused on Medical Research and Development, which includes Medical Marijuana Research and Development.
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM